Xia Lin
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Pharmacology top 1%
- Berberine and alkaloids research
- Pharmacological Effects of Natural Compounds
Papers in
-
- Drug Solubulity and Delivery Systems 16
- Advanced Drug Delivery Systems 15
-
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- Xing Tang (27 shared papers)Xing Tang (7 shared papers)Keru Zhang (8 shared papers)Shenshen Yang (5 shared papers)Bin Tian (5 shared papers)Yu Zhang (15 shared papers)Haibing He (8 shared papers)Yuqiang Miao (2 shared papers)
- Journals
- International Journal of Pharmaceutics (10 papers)Journal of Drug Delivery Science and Technology (6 papers)Talanta (4 papers)Pharmaceutical Research (3 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)
- Partner nations
- ChinaNorwayUnited States
In The Last Decade
Xia Lin
62 papers receiving 2.7k citations
Xia Lin's Hit Papers
Peers
Comparison fields: 5 of 134
- Pharmaceutical Science 703
- Pharmacology 368
- Biomaterials 493
- Pharmacology 295
- Molecular Medicine 78
Countries citing papers authored by Xia Lin
This map shows the geographic impact of Xia Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Lin more than expected).
Fields of papers citing papers by Xia Lin
This network shows the impact of papers produced by Xia Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Lin. The network helps show where Xia Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xia Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 315 | |
| 2 | 2014 | 311 | |
| 3 | 2003 | 246 | |
| 4 | An “essential herbal medicine”—licorice: A review of phytochemicals and its effects in combination preparations Hit paper breakdown → | 2019 | 238 |
| 5 | 2006 | 118 | |
| 6 | 2014 | 110 | |
| 7 | 2018 | 105 | |
| 8 | 2013 | 99 | |
| 9 | 2006 | 87 | |
| 10 | 2018 | 64 | |
| 11 | 2012 | 57 | |
| 12 | 2010 | 56 | |
| 13 | 2011 | 47 | |
| 14 | 2008 | 41 | |
| 15 | 2007 | 39 | |
| 16 | 2012 | 39 | |
| 17 | 2012 | 37 | |
| 18 | 2004 | 36 | |
| 19 | 2019 | 35 | |
| 20 | 2008 | 33 |
About Xia Lin
Xia Lin is a scholar working on Pharmaceutical Science, Biomaterials, Pharmacology, Pharmacology and Analytical Chemistry, having authored 65 papers that have together received 2.8k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (16 papers), Advanced Drug Delivery Systems (15 papers), Cancer Treatment and Pharmacology (5 papers), RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), Analytical Methods in Pharmaceuticals (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). The work is most often cited by research in Pharmaceutical Science (703 citations), Pharmacology (368 citations), Biomaterials (493 citations), Pharmacology (295 citations) and Molecular Medicine (78 citations). Xia Lin has collaborated with scholars based in China, Norway and United States. Frequent co-authors include Xing Tang, Xing Tang, Keru Zhang, Shenshen Yang, Bin Tian, Yu Zhang, Haibing He, Yuqiang Miao, Wei Chen and Ziyi Yang. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Drug Delivery Science and Technology, Talanta, Pharmaceutical Research and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.